Wyss Center for Bio and Neuroengineering
Overview
Wyss Center for Bio and Neuroengineering is a non-profit research and development foundation that accelerates the development of neurotechnology to improve the lives of people with neurological and mental health disorders.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| dEEGtal Insight | Dec 2024 | Seed | Lead |
| Clee Medical SA | Feb 2026 | Seed | Co-investor |
| Artiria Medical | Feb 2024 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Wyss Center for Bio and Neuroengineering based?
Wyss Center for Bio and Neuroengineering is headquartered in Geneva, Switzerland.
When was Wyss Center for Bio and Neuroengineering founded?
Wyss Center for Bio and Neuroengineering was founded in 2014.
How many portfolio companies does Wyss Center for Bio and Neuroengineering have?
Wyss Center for Bio and Neuroengineering has 3 portfolio companies in Caplight's dataset.
What are some companies in Wyss Center for Bio and Neuroengineering's portfolio?
Portfolio companies visible on Caplight include dEEGtal Insight, Clee Medical SA, Artiria Medical.
What was Wyss Center for Bio and Neuroengineering's most recent investment shown here?
Wyss Center for Bio and Neuroengineering's most recent investment in this portfolio sample was in Clee Medical SA in 2026.
What sectors does Wyss Center for Bio and Neuroengineering focus on?
Wyss Center for Bio and Neuroengineering focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.
What company stages does Wyss Center for Bio and Neuroengineering focus on?
Wyss Center for Bio and Neuroengineering typically invests at the Early stage.